4.7 Article

Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Biomarkers for breast cancer immunotherapy: PD-L1, TILs, and beyond

Alessandro Rizzo et al.

Summary: This article discusses potential predictors of response to ICIs in breast cancer, including PD-L1 expression, TILs, TMB, and other biomarkers. Valuable data on predictive biomarkers have emerged, supporting the use of immunotherapy in metastatic triple-negative breast cancer, although further investigations are needed.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

Article Chemistry, Medicinal

Therapeutic strategies to overcome cisplatin resistance in ovarian cancer

Mengdi Song et al.

Summary: This review discusses the chemotherapeutic drugs and phytochemicals developed to overcome cisplatin-resistance ovarian cancer (CROC), highlighting the significance of combination therapy and the use of a nanoparticle delivery system in reversing cisplatin resistance.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Oncology

Prevalence of comprehensiveDNAdamage repair gene germline mutations in Chinese prostate cancer patients

Junlong Wu et al.

Summary: This study provides a comprehensive view of germline DDR gene mutations in PCa patients and identifies two potential PCa predisposition genes, POLN and POLG, not previously reported in the Western population, highlighting the necessity of customizing a multigene panel for Chinese PCa patients.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Biochemistry & Molecular Biology

Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses

Can Cui et al.

Summary: The study found that the enrichment of TFH cell transcriptional signature in lung adenocarcinoma patients is correlated with GC B cell signature and prolonged survival. Interactions between tumor-specific TFH and GC B cells are crucial for tumor control and effector CD8 T cell function.
Review Oncology

Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapy

Rayhaan M. M. Ali et al.

Summary: Breast cancer is largely attributed to defects in the DNA damage response pathway, particularly in the homologous recombination pathway. Mutations in genes encoding HR proteins have been identified as a cause of HR deficiency, affecting breast cancer development, progression, and response to therapy. Understanding HR processes and developing targeted therapies such as PARP inhibitors are key in addressing challenges like therapy resistance and improving tumor responses.

GENES CHROMOSOMES & CANCER (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Biochemistry & Molecular Biology

DNA damage response inhibitors: An avenue for TNBC treatment

Juan Jin et al.

Summary: DDR is essential for the survival of TNBC, as TNBC exhibits replication stress and DNA damage requiring DDR for maintenance. Aberrant genetic alterations in DDR pathways in TNBC make it more susceptible to DDR inhibitors.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Biotechnology & Applied Microbiology

Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions

Binsheng Gong et al.

Summary: All panels exhibit high sensitivity for variants within the 5-20% VAF range in high-confidence coding regions, but sensitivity decreases when using VAF thresholds due to variability in VAF measurements. Enforcing a VAF threshold for reporting reduces false positive calls, and false positive rate is higher outside high-confidence coding regions, leading to lower reproducibility. Region restriction and VAF thresholds result in low technical variability in estimating promising biomarkers and tumor mutational burden.

GENOME BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis

Dingxie Liu et al.

Summary: Basal-like breast cancer (BLBC) is a high-grade invasive breast cancer subtype with high risk of recurrence and poor survival. Immune activation, specifically involving IFN-alpha, IFN-gamma, and TNF-alpha pathways, negatively correlates with BLBC recurrence, while TGF-beta and STAT3 pathways show positive or no association. Combining TNF-alpha/TGF-beta pathways improves prediction of recurrence and chemotherapy response in BLBCs.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Review Medicine, General & Internal

Breast Cancer Treatment A Review

Adrienne G. Waks et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Review Oncology

Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy

Burak Yasin Aktas et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2019)

Review Oncology

Regulation of Immunity in Breast Cancer

Chidalu A. Edechi et al.

CANCERS (2019)

Review Biochemistry & Molecular Biology

Immune Checkpoint Inhibitors: Basics and Challenges

Bin Li et al.

CURRENT MEDICINAL CHEMISTRY (2019)

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

Article Biochemistry & Molecular Biology

COSMIC: somatic cancer genetics at high-resolution

Simon A. Forbes et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Oncology

Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma

Erin M. Parry et al.

JOURNAL OF THORACIC ONCOLOGY (2017)

Review Surgery

The Role of Genetic Testing in Patients With Breast Cancer A Review

Olivia M. Valencia et al.

JAMA SURGERY (2017)

Review Biochemistry & Molecular Biology

Targeting the DNA Damage Response in Cancer

Mark J. O'Connor

MOLECULAR CELL (2015)

Editorial Material Genetics & Heredity

BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective

W. D. Foulkes

CLINICAL GENETICS (2014)

Article Multidisciplinary Sciences

Integrated analysis of germline and somatic variants in ovarian cancer

Krishna L. Kanchi et al.

NATURE COMMUNICATIONS (2014)

Article Biochemistry & Molecular Biology

VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing

Daniel C. Koboldt et al.

GENOME RESEARCH (2012)

Review Oncology

DNA repair dysregulation from cancer driver to therapeutic target

Nicola J. Curtin

NATURE REVIEWS CANCER (2012)

Review Biochemistry & Molecular Biology

Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression

Brian F. Zamarron et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)

Article Biochemistry & Molecular Biology

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

Aaron McKenna et al.

GENOME RESEARCH (2010)

Article Biochemistry & Molecular Biology

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

Kai Wang et al.

NUCLEIC ACIDS RESEARCH (2010)

Article Biochemical Research Methods

Fast and accurate short read alignment with Burrows-Wheeler transform

Heng Li et al.

BIOINFORMATICS (2009)